These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 702279)

  • 41. Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing.
    Maskasame C; Lankford SM; Bai SA
    Drug Metab Dispos; 1993; 21(1):156-61. PubMed ID: 8095211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of hydralazine on the pharmacokinetics of orally administered d-propranolol and lidocaine in conscious dogs.
    Heinzow BG; Somogyi A; McLean AJ
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):5-14. PubMed ID: 3592861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transplacental and mammary passage of radioactivity in rats treated vaginally and orally with [14C]propranolol.
    Buttar HS; Moffatt JH; Bura C
    J Toxicol Environ Health; 1988; 24(1):1-18. PubMed ID: 3373560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactive effect of ethanol administration on blood propranolol levels in rats.
    Moriya F; Ishizu H
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):360-6. PubMed ID: 1772375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereochemistry of tissue distribution of racemic propranolol in the dog.
    Walle UK; Thibodeaux H; Privitera PJ; Walle T
    Chirality; 1989; 1(3):192-6. PubMed ID: 2642048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose-dependent bioavailability of propranolol.
    Kopitar Z; Vrhova B; Lenardic A; Cvelbar P; Zorz M; Francetić I
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):319-22. PubMed ID: 3733282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
    Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A readily obtainable analog of propranolol suitable for use as internal standard in chromatographic assays for propranolol.
    Gal J; Rhodes PJ; Nakata LM; Bloedow DC
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):255-66. PubMed ID: 4023411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrasts between pindolol and propranolol concentration-response relationships.
    Carruthers SG; Pacha WL; Aellig WH
    Br J Clin Pharmacol; 1985 Oct; 20(4):417-20. PubMed ID: 4074610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of age on plasma levels of propranolol and practolol in man.
    Castleden CM; Kaye CM; Parsons RL
    Br J Clin Pharmacol; 1975 Aug; 2(4):303-6. PubMed ID: 1233989
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of propranolol: a review.
    Shand DG
    Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of the absorption and removal of propranolol in hypertensive patients during therapy.
    Chidsey CA; Morselli P; Bianchetti G; Morganti A; Leonetti G; Zanchetti A
    Circulation; 1975 Aug; 52(2):313-8. PubMed ID: 1149212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propranolol disposition after acute myocardial infarction.
    Paxton JW; Norris RM
    Clin Pharmacol Ther; 1984 Sep; 36(3):337-42. PubMed ID: 6467793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
    Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
    Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The structure of propranolol hemisuccinate.
    Nelson WL; Walker RB
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):435-45. PubMed ID: 734223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dog.
    Bai SA; Easterling DE; Wilson MJ; Walle UK; Haney CA; Peet NP; Pruett JK; Walle T
    Drug Metab Dispos; 1989; 17(5):495-505. PubMed ID: 2573492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.